CollPlant Biotechnologies (CLGN) Cash from Operations (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Cash from Operations of 2935000.0 for Q4 2025, down 2.02% on a QoQ basis from 2877000.0 in Q3 2025, and up 15.27% year-over-year from 2546165.79 in Q4 2024.
CollPlant Biotechnologies (CLGN) Cash from Operations (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Cash from Operations history runs 8 years deep, the most recent figure standing at 2935000.0 for Q4 2025.
- Quarterly Cash from Operations rose 15.27% year-over-year to 2935000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 11716000.0 (up 16.87% YoY) and the FY2025 annual result came in at 9419000.0, up 33.17% from the prior year.
- Cash from Operations was 2935000.0 for Q4 2025 at CollPlant Biotechnologies, down from 2877000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 11118000.0 in Q1 2021 and bottomed at 13698000.0 in Q4 2022.
- A 5-year average of 2455631.58 and a median of 3212000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations soared 530.1% — and 2022, when it sank 466.03%.
- CollPlant Biotechnologies' Cash from Operations stood at 2420000.0 in 2021, then sank by 466.03% to 13698000.0 in 2022, then surged by 82.88% to 2345000.0 in 2023, then plunged by 47.72% to 3464000.0 in 2024, then grew by 15.27% to 2935000.0 in 2025.
- Business Quant data shows CLGN's Cash from Operations at 2935000.0 in Q4 2025, 2877000.0 in Q3 2025, and 2440000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.94 Mn |
| Dec 31, 2025 | -2.94 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Dec 31, 2024 | -3.46 Mn |
| Dec 31, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.93 Mn |
| Jun 30, 2024 | -3.93 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Sep 30, 2023 | 6.78 Mn |
| Sep 30, 2023 | 6.78 Mn |
| Jun 30, 2023 | -3.74 Mn |
| Jun 30, 2023 | -3.74 Mn |